RTL treatment significantly decreased the frequency of CD4+, CD8+, and CD3+ T cells and increased B cells in the spleen of young mice following MCAO suggesting that in young mice, RTL treatment counteracts changes in immune cell subsets that occur in the spleen after stroke. This evidence concerns the gene CD8A and stroke disorder.